Disease Models & Mechanisms

Scope & Guideline

Transforming Research into Therapeutic Insights

Introduction

Welcome to the Disease Models & Mechanisms information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Disease Models & Mechanisms, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1754-8403
PublisherCOMPANY BIOLOGISTS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2008 to 2024
AbbreviationDIS MODEL MECH / Dis. Model. Mech.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND

Aims and Scopes

The journal 'Disease Models & Mechanisms' primarily focuses on the development and application of innovative models for studying human diseases, aiming to bridge the gap between basic research and clinical applications. The journal publishes high-quality research that utilizes diverse methodologies across various model organisms to explore disease mechanisms and therapeutic strategies.
  1. Disease Modeling:
    The journal emphasizes the creation and refinement of various disease models, including mouse, zebrafish, and cellular systems, to facilitate a better understanding of human diseases.
  2. Mechanistic Insights:
    Research published in the journal often delves into the cellular and molecular mechanisms underlying diseases, providing insights that can lead to novel therapeutic approaches.
  3. Translational Research:
    The focus is also on translational studies that aim to apply findings from basic research to clinical settings, thereby improving patient outcomes.
  4. Multiscale Approaches:
    The journal encourages research that integrates data from multiple scales, from molecular to organismal levels, to comprehensively understand disease processes.
  5. Interdisciplinary Collaboration:
    The journal promotes collaboration across disciplines, including genetics, pharmacology, and bioinformatics, to advance the understanding of disease mechanisms and develop effective interventions.
Recent publications in 'Disease Models & Mechanisms' indicate a shift towards emerging themes that are gaining traction in the research community. These trends reflect advancements in technology and an increased understanding of complex disease mechanisms.
  1. Organoid and Stem Cell Models:
    The use of organoids and stem cell-derived models is on the rise, allowing for more physiologically relevant studies of human diseases and personalized medicine approaches.
  2. Multi-Omics Approaches:
    There is a growing trend towards integrating multi-omics data (genomics, transcriptomics, proteomics) to provide a holistic view of disease mechanisms, enhancing the understanding of complex interactions.
  3. Host-Microbiome Interactions:
    Research focusing on the interactions between host organisms and their microbiomes is emerging, particularly in the context of metabolic diseases and immune responses.
  4. Therapeutic Target Discovery:
    A notable increase in studies aimed at identifying novel therapeutic targets through advanced screening methods is evident, reflecting the journal's commitment to translational research.
  5. Disease Relevance of Non-Coding RNAs:
    The role of non-coding RNAs in disease mechanisms is gaining attention, with researchers increasingly exploring their potential as biomarkers and therapeutic targets.

Declining or Waning

In contrast to its evolving focus areas, certain themes within 'Disease Models & Mechanisms' appear to be losing prominence over recent years. This decline may reflect shifts in research priorities or advancements in methodologies that render previous approaches less relevant.
  1. Traditional Animal Models:
    While animal models remain crucial, there is a noticeable decline in studies solely relying on traditional mouse models, with a growing emphasis on more diverse and innovative models such as organoids and iPSCs.
  2. Single-Focus Studies:
    Research that concentrates on isolated aspects of disease mechanisms without considering broader biological contexts is becoming less common, as the field moves towards more integrative approaches.
  3. Basic Descriptive Studies:
    The journal is seeing fewer publications that provide only descriptive data without mechanistic insights, as there is a stronger demand for studies that elucidate underlying pathways or therapeutic implications.
  4. Generalized Findings Across Diseases:
    Papers that attempt to draw broad conclusions applicable to multiple diseases without specific mechanistic support are decreasing, as the field values specificity and targeted interventions.

Similar Journals

Animal Cells and Systems

Elevating Understanding of Animal Systems and Cells
Publisher: TAYLOR & FRANCIS LTDISSN: 1976-8354Frequency: 6 issues/year

Animal Cells and Systems, published by TAYLOR & FRANCIS LTD, is a prominent open-access journal that has been disseminating high-quality research since 2017. With an ISSN of 1976-8354 and an E-ISSN of 2151-2485, this journal is dedicated to advancing the understanding of animal cellular biology and the intricate systems that govern organismal functions. Recognized for its rigorous peer-review process, it holds an esteemed position in the academic community, boasting a Q1 ranking in Animal Science and Zoology and a Q2 ranking in Biochemistry, Genetics and Molecular Biology for 2023. The journal is indexed in Scopus, ranked #79/490 in Animal Science and Zoology and #85/221 in General Biochemistry, Genetics, and Molecular Biology, affirming its impact and relevance in these fields. With a commitment to providing researchers, professionals, and students with vital insights and cutting-edge research, Animal Cells and Systems is an essential resource for those looking to explore the complex landscapes of animal biology.

Molecular Biomedicine

Advancing the Frontiers of Molecular Science
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Molecular Biomedicine is a prestigious peer-reviewed journal published by SpringerNature, dedicated to advancing the fields of molecular biology and molecular medicine. With a commendable Q1 ranking in both categories for 2023, this journal stands out for its rigorous exploration of the biochemical processes underlying health and disease. Operating out of Germany, Molecular Biomedicine aims to provide comprehensive insights into cutting-edge research, facilitating interdisciplinary collaboration among researchers, healthcare professionals, and students alike. The journal's impact is reflected in its Scopus rankings, placing it in the upper echelons of the fields of biochemistry, genetics, and molecular biology. As an open access platform, it commits to disseminating knowledge widely, ensuring that pivotal discoveries are accessible to all. Researchers looking to publish in a dynamic environment that prioritizes innovation and application in the biomedical sciences will find Molecular Biomedicine an ideal outlet for their work.

Molecular Biology Research Communications

Advancing the frontiers of molecular discovery.
Publisher: SHIRAZ UNIVISSN: 2322-181XFrequency: 4 issues/year

Molecular Biology Research Communications is a distinguished academic journal published by Shiraz University, focusing on the critical and rapidly evolving fields of biochemistry and molecular biology. With an ISSN of 2322-181X and an E-ISSN of 2345-2005, this journal serves as an essential platform for researchers, professionals, and students to disseminate significant findings that contribute to the advancement of knowledge in these disciplines. The journal, operating from Shiraz, Iran, is notable for its contributions from both local and international scholars, offering invaluable insights and fostering scientific collaboration. Although currently indexed in the Q4 quartile across its categories, the journal aims to enhance its impact and visibility in the field as it converges years of research from 2017 to 2024. While the open access option is not available, the journal's commitment to high-quality peer-reviewed research provides a respected avenue for publication.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Shaping the Future of Experimental Pathology
Publisher: WILEYISSN: 0959-9673Frequency: 6 issues/year

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Advancing the Frontiers of Cellular and Molecular Discovery
Publisher: WILEYISSN: 1582-1838Frequency: 12 issues/year

Journal of Cellular and Molecular Medicine, published by Wiley, stands at the forefront of research excellence in the fields of cell biology and molecular medicine. With an impressive impact factor reflected in its 2023 Q2 category ranking for both Cell Biology and Molecular Medicine, this journal provides a vital platform for researchers and professionals alike, fostering innovative findings and groundbreaking discoveries since its inception in 2000. Maintaining an open access policy since 2012, the journal ensures that knowledge is freely disseminated, promoting collaboration and progress across the scientific community. With robust rankings in the Scopus database, including a position within the top 85th percentile in Molecular Medicine, the journal remains committed to advancing understanding of cellular functions and their implications in health and disease. Researchers, professionals, and students will find a treasure of high-quality articles and reviews that not only catalyze academic dialogue but also contribute significantly to practical applications in the life sciences.

Non-Coding RNA

Empowering Researchers with Open Access to RNA Science
Publisher: MDPIISSN: Frequency: 6 issues/year

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Connecting disciplines to illuminate the science of life.
Publisher: POLISH PHYSIOLOGICAL SOCISSN: 0867-5910Frequency: 4 issues/year

JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY is a distinguished publication presented by the POLISH PHYSIOLOGICAL SOC, dedicated to advancing the fields of physiology and pharmacology. Since its inception in 1991, this journal has maintained a commitment to disseminating vital research findings, contributing to the growing body of knowledge essential for understanding complex biological systems and their interactions with pharmacological agents. With a consistent focus on interdisciplinary studies, the journal holds a Q3 categorization in both Medicine and Pharmacology as well as Physiology for 2023, reflecting its relevance in these crucial fields. Although specific access options are not available, the journal's robust indexing and rankings in Scopus signify its credibility and the high caliber of its contributions, appealing to researchers, professionals, and students alike. Operating from the picturesque Jagiellonian University in Krakow, Poland, this journal not only enriches the academic landscape but also fosters global collaboration and innovation in the life sciences.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Unveiling Cellular Mechanisms for Tomorrow's Discoveries.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0363-6143Frequency: 12 issues/year

Welcome to the American Journal of Physiology-Cell Physiology, a premier publication produced by the American Physiological Society that has been a cornerstone of research in cell biology and physiology since its inception in 1977. With its esteemed reputation solidified by its Q1 ranking in both Cell Biology and Physiology categories as of 2023, this journal serves as a vital resource for researchers, professionals, and students pursuing cutting-edge discoveries in cellular mechanisms. The journal is published in the United States and is recognized for its rigorous peer-review process, contributing to its high impact factor and prestigious standing—ranking #32 out of 193 in Physiology and #75 out of 285 in Cell Biology according to Scopus. While the journal does not provide open access, it remains an essential repository of knowledge, fostering innovation and advancing the field with original research articles, reviews, and commentaries. Join us in exploring the molecular intricacies of life through the compelling research that the American Journal of Physiology-Cell Physiology has to offer.

MOLECULAR PHARMACOLOGY

Elevating Understanding of Molecular Drug Actions
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0026-895XFrequency: 12 issues/year

MOLECULAR PHARMACOLOGY, published by the American Society for Pharmacology and Experimental Therapeutics, is an influential peer-reviewed journal dedicated to advancing the field of pharmacology through comprehensive research on molecular mechanisms of drug action. With an impressive historic convergence from 1965 to 2024, this journal plays a pivotal role in disseminating high-quality research, showcasing significant findings that impact both clinical and experimental pharmacology. Notably, it holds a distinguished Q1 ranking in Pharmacology and a Q2 ranking in Molecular Medicine as of 2023, reflecting its prominence in the academic community. Researchers and practitioners engaged in pharmacological studies will benefit from the journal’s focus on new therapeutic strategies, drug development, and the molecular basis of drug action. While MOLECULAR PHARMACOLOGY is not an open-access journal, it offers a wealth of knowledge behind a subscription model, ensuring that contributors and readers maintain a high standard of academic rigor. Address all inquiries to the editorial office located at 9650 Rockville Pike, Bethesda, MD 20814-3995, United States.

GENES & DEVELOPMENT

Bridging Breakthroughs in Genetics and Development
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 0890-9369Frequency: 24 issues/year

GENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.